研究报告 |
|
|
|
|
抗CD133胞外区骆驼多克隆抗体的制备及鉴定 |
翟田甜, 马晓玲, 木亚沙尔·买买提拉洪, 李玲霞, 李江伟 |
新疆大学生命科学与技术学院 新疆生物资源基因工程重点实验室 乌鲁木齐 830046 |
|
Preparation and Characterization of Polyclonal Antibody Against CD133 Derived from Camel |
ZHAI Tian-tian, MA Xiao-ling, Muyassar, M LI Ling-xia, LI Jiang-wei |
Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi 830046, China |
引用本文:
翟田甜, 马晓玲, 木亚沙尔·买买提拉洪, 李玲霞, 李江伟. 抗CD133胞外区骆驼多克隆抗体的制备及鉴定[J]. 中国生物工程杂志, 2014, 34(8): 24-28.
ZHAI Tian-tian, MA Xiao-ling, Muyassar, M LI Ling-xia, LI Jiang-wei. Preparation and Characterization of Polyclonal Antibody Against CD133 Derived from Camel. China Biotechnology, 2014, 34(8): 24-28.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20140804
或
https://manu60.magtech.com.cn/biotech/CN/Y2014/V34/I8/24
|
[1] Soltanian S, Matin M M. Cancer stem cells and cancer therapy. Tumor Biol, 2011, 32(3): 425-440.
[2] Jin X, Jung J E, Beck S, et al. Cell surface Nestin is a biomarker for glioma stem cells. Biochem Biophys Res Commun, 2013, 433(4): 496-501.
[3] Boman B M, Wicha M S. Cancer stem cells: a step toward the cure. Clin Oncol, 2008, 26(17): 2795-2799.
[4] Ferrandina G, Petrillo M, Bonanno G, et al. Targeting CD133 antigen in cancer. Expert Opin Ther Targets, 2009, 13(7): 823-837.
[5] Bao S, Wu Q, McLendon R E, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 2006, 444: 756-760.
[6] Naujokat C. Monoclonal antibodies against human cancer stem cells. Immunotherapy, 2014, 6(3): 290-308.
[7] Smith L M, Nesterova A, Ryan M C, et al. CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer, 2008, 99(1): 100-109.
[8] Akita M, Tanaka K, Murai N, et al. Detection of CD133 (prominin-1) in a human hepatoblastoma cell line (HuH-6 clone 5). Microsc Res Tech, 2013, 76(8): 844-852.
[9] Chen H, Luo Z, Sun W, et al. Low glucose promotes CD133mAb-elicited cell death via inhibition of autophagy in hepatocarcinoma cells. Cancer Lett, 2013, 336(1): 204-212.
[10] John R Ohlfest, David M. Immunotoxin targeting CD133+ breast carcinoma cells. Drug Deliv Transl Res, 2013, 3: 195-204.
[11] Skubitz A P, Taras E P, Boylan K L, et al. Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression. Gynecologic Oncology, 2013, 130 (3): 579-587.
[12] De Meyer T, Muyldermans S, Depicker A. Nanobody-based products as research and diagnostic tools. Trends Biotechnol, 2014, 32(5): 263-270.
[13] Griffin L M, Snowden J R, Lawson A D, et al. Analysis of heavy and light chain sequences of conventional camelid antibodies from Camelus dromedarius and Camelus bactrianus species. J Immunol Methods, 2014, 405: 35-46.
[14] van der Linden R, de Geus B, Stok W, et al. Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama. J Immunol Methods, 2000, 240(1-2): 185-195.
[15] 夏丽洁, 苏幼红, 张清华, 等. 新疆双峰驼抗血清中重链抗体的分离鉴定. 中国农业科学, 2010, 43(17): 3660-3666. Xia L J, Su Y H, Zhang Q H, et al. Isolation and identification of heavy chain antibodies derived from immunized xinjiang Camelus bactrianus. Scientia Agricultura Sinica, 2010, 43(17): 3660-3666.
[16] 夏丽洁, 苏幼红, 晏鹏飞, 等. 采用双峰驼重链抗体特异的抗血清检测不同抗原免疫骆驼过程中血清重链抗体的水平. 中国畜牧兽医, 2012, 39(4): 68-72. Xia L J, Su Y H, Yan PF, et al. The dynamic change of heavy chain antibody in Camelus bactrianus during the immunization with different antigens assayed by heavy chain antibody specific antiserum. China Animal Husbandry and Veterinary Medicine, 2012, 39(4): 68-72.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|